Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,460Revenue (TTM) $M165Net Margin (%)-92.8Altman Z-Score-1.6
Enterprise Value $M3,319EPS (TTM) $-1.1Operating Margin %-68.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-92.3Higher ROA y-yN
Price/Book39.110-y EBITDA Growth Rate %--Quick Ratio5.8Cash flow > EarningsY
Price/Sales18.75-y EBITDA Growth Rate %-25.3Current Ratio5.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-31.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M154ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NKTR

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NKTR is held by these investors:



NKTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Thomsen Jillian B.SVP & Chief Accounting Officer 2017-03-20Sell112,500$19.6914.22view
CHESS ROBERTDirector 2017-03-14Sell5,000$15.4145.94view
Labrucherie Gil MSVP & CFO 2017-03-03Sell200,000$15.1648.35view
Lingnau LutzDirector 2017-02-21Sell30,000$13.0871.94view
Doberstein Stephen KSVP & Chief Scientific Officer 2017-02-16Sell1,261$13.1471.16view
Thomsen Jillian B.SVP & Chief Accounting Officer 2017-02-16Sell1,965$13.1471.16view
ROBIN HOWARD WPresident & CEO 2017-02-16Sell8,636$13.1471.16view
Nicholson JohnSVP & COO 2017-02-16Sell3,237$13.1471.16view
Labrucherie Gil MSVP & CFO 2017-02-16Sell2,359$13.1471.16view
Hora ManinderSVP Pharma Dev & Mfg Ops 2017-02-16Sell2,195$13.1471.16view

Quarterly/Annual Reports about NKTR:

News about NKTR:

Articles On GuruFocus.com
4 Biotech Stocks to Watch Mar 22 2017 
Weekly CEO Sales Highlight: Monolithic Power Systems, Five Prime Therapeutics, Nektar Therapeutics Feb 15 2016 
Weekly CEO Sells Highlight: Cadence Design Systems Inc., Nektar Therapeutics Inc., Netflix Inc., Pho Sep 27 2015 
Weekly Guru Bargains Highlights: AKAM, NKTR, LOGI, FFIV, LCC Apr 16 2011 
Weekly Guru Bargains Highlights: AMSC, LOGI, NKTR, DAL, AIG Apr 09 2011 
Four Guru Stocks near New Lows: FBN, HOME, NKTR, PETS Feb 07 2011 
MannKind: Deja Vu for the FDA and Afrezza Dec 29 2010 
Nektar Therapeutics Reports Operating Results (10-Q) Nov 04 2010 
Nektar Therapeutics Reports Operating Results (10-Q) Jul 29 2010 
Nektar Therapeutics Reports Operating Results (10-Q) May 06 2010 

More From Other Websites
4 Biotech Stocks to Watch Mar 22 2017
Nektar Therapeutics (NKTR): Here’s What Just Happened Mar 21 2017
Nektar's Pain Drug Positive in Phase III Study; Shares Gain Mar 21 2017
Stocks of Nektar Therapeutics and CytomX Therapeutics Rise on FDA Trial News Mar 21 2017
Biotech Hits 11-Year High On Potential To Dethrone Oxycodone Mar 20 2017
Nektar Pharma Opioid Drug Shows Promise In Phase 3 Mar 20 2017
Nektar, AMD, Esperion, and More: Here’s Why These Five Stocks Are Surging Mar 20 2017
A new painkiller is being designed that won't get users high, and it could save thousands of lives Mar 20 2017
Monday’s Top Biopharma Movers Mar 20 2017
Biotech Premarket Movers: CytomX, Aevi, Esperion Mar 20 2017
Nektar Therapeutics' stock jumps after positive results of its pain treatment drug Mar 20 2017
NEKTAR THERAPEUTICS Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Mar 20 2017
Nektar's opioid painkiller succeeds in key late-stage study Mar 20 2017
NKTR-181 Meets Primary and Secondary Endpoints in Phase 3 SUMMIT-07 Study in Chronic Pain Mar 20 2017
Nektar Addiction-Resistant Opioid Reduces Chronic Pain in Late-Stage Study Mar 20 2017
Nektar Surges by Most Since 1996 After Opioid Trial Success Mar 20 2017
NEKTAR THERAPEUTICS Financials Mar 07 2017
Nektar Therapeutics :NKTR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017 Mar 03 2017
Nektar Therapeutics (NKTR) Loss Wider than Expected in Q4 Mar 03 2017
Biotech Industry Rally Grows as Trump Vows to Cut Regulations: Today's Reports on Aurinia... Mar 03 2017
Nektar to Webcast Presentation at Cowen and Company's 37th Annual Health Care Conference in Boston Mar 02 2017
Nektar reports 4Q loss Mar 01 2017
Nektar to Announce Financial Results for the Third Quarter 2016 on Thursday, November 3, 2016, After... Nov 01 2016
Bristol-Myers Squibb and Nektar Therapeutics Announce Oncology Clinical Collaboration to Evaluate... Sep 27 2016
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2016 Aug 03 2016
Nektar to Announce Financial Results for the Second Quarter 2016 on Wednesday, August 3, 2016, After... Jul 27 2016
Preclinical Data Presented at ASCO 2016 Annual Meeting Demonstrate that Single-Agent NKTR-214... Jun 06 2016
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the Jefferies 2016 Global... Jun 02 2016
Nektar Therapeutics Announces Executive Management Promotions Jun 02 2016
Nektar Therapeutics and Daiichi Sankyo Europe GmbH Sign European Licensing Agreement for ONZEALD™... Jun 01 2016
Nektar Therapeutics Reports Financial Results for the First Quarter of 2016 May 03 2016
Nektar to Announce Financial Results for the First Quarter 2016 on Tuesday, May 3, 2016, After Close... Apr 28 2016
Preclinical Data Presented at AACR Demonstrate that Combining NKTR-214 with Checkpoint Blockade is... Apr 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)